ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 157 filers reported holding ZOGENIX INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,446,000 | +7.0% | 88,977 | 0.0% | 0.05% | +6.8% |
| Q3 2021 | $1,352,000 | -12.1% | 88,977 | 0.0% | 0.04% | -12.0% |
| Q2 2021 | $1,538,000 | -11.5% | 88,977 | 0.0% | 0.05% | -16.7% |
| Q1 2021 | $1,737,000 | -2.4% | 88,977 | 0.0% | 0.06% | -4.8% |
| Q4 2020 | $1,779,000 | -70.2% | 88,977 | -73.3% | 0.06% | -71.9% |
| Q3 2020 | $5,978,000 | +2.8% | 333,402 | +54.8% | 0.22% | +1.4% |
| Q2 2020 | $5,818,000 | +9.2% | 215,406 | 0.0% | 0.22% | -8.3% |
| Q1 2020 | $5,327,000 | -5.1% | 215,406 | +100.0% | 0.24% | +13.7% |
| Q4 2019 | $5,615,000 | +126.0% | 107,703 | +73.5% | 0.21% | +96.3% |
| Q3 2019 | $2,485,000 | -58.1% | 62,074 | -50.0% | 0.11% | -55.4% |
| Q2 2019 | $5,932,000 | +20.1% | 124,148 | +38.3% | 0.24% | +20.4% |
| Q1 2019 | $4,938,000 | +22.0% | 89,762 | -19.2% | 0.20% | +16.2% |
| Q4 2018 | $4,048,000 | +23.3% | 111,025 | +67.8% | 0.17% | +45.4% |
| Q3 2018 | $3,283,000 | +110.0% | 66,182 | +87.2% | 0.12% | +101.7% |
| Q2 2018 | $1,563,000 | – | 35,352 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,502,259 | $40,662,000 | 13.40% |
| HealthInvest Partners AB | 195,000 | $3,169,000 | 4.47% |
| CADIAN CAPITAL MANAGEMENT, LP | 4,090,846 | $66,476,000 | 3.66% |
| Prosight Management, LP | 362,909 | $5,897,000 | 3.53% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,284,705 | $20,876,000 | 1.97% |
| Kynam Capital Management, LP | 205,800 | $3,344,000 | 1.79% |
| Western Standard LLC | 160,656 | $2,611,000 | 1.54% |
| Ikarian Capital, LLC | 590,400 | $9,594,000 | 1.43% |
| RA Capital Management | 3,333,700 | $54,173,000 | 0.96% |
| Knott David M Jr | 134,688 | $2,189,000 | 0.74% |